Search Results 1151-1160 of 17088 for monoclonal antibody

1. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

   History of severe allergic or anaphylactic reaction to monoclonal antibody therapy. Confirmed diagnosis of progressive multifocal leukoencephalopathy ...

2. Hematology - Clinical trials

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

3. Publications - Talal Hilal, M.D. - Mayo Clinic

   ... monoclonal B-cell lymphocytosis. Br J Haematol ... Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis. ... Incidence, risk ...

4. Autoimmune pancreatitis - Diagnosis and treatment - Mayo Clinic

   Autoimmune pancreatitis is a relatively uncommon disease of the pancreas that may be mistaken for pancreatic cancer.

5. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

   Baseline positive donor-specific anti-HLA antibody testing (DSA). History of ... antibody (anti-HBsAb), or exhibiting a positive HBV polymerase chain ...

6. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Ongoing treatment with other monoclonal antibodies (e.g., infliximab, rituximab), immunomodulators (eg, abatacept, methotrexate, azathioprine, cyclosporine) ...

7. Scientists discover autoimmune disease associated with testicular cancer - Mayo Clinic News Network

   Technology that uncovered antibody has potential to identify other autoimmune diseases. ROCHESTER, Minn. — Using advanced technology, scientists at Chan ...

8. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

   Subject who received any prior monoclonal antibodies against PD-1 or PD-L1 and/or any prior: Arm A only: ImiDs (eg, lenalidomide, thalidomide);; Arm B ...

9. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC - Mayo Clinic

   (including monoclonal antibodies). 3. Concurrent cytotoxicity chemotherapy, immunotherapy, radioligand therapy, PARP inhibitor, biological therapy or ...

10. Mayo Mouse Helps Fight Multiple Myeloma

    It almost always starts as a relatively benign condition known as monoclonal gammopathy of undetermined significance (MGUS), which was originally identified at ...